REPORT ID 6480

Global Vascular Endothelial Growth Factor B Sales Market Report 2017

Publish Date
26-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the global Vascular Endothelial Growth Factor B market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Vascular Endothelial Growth Factor B for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Vascular Endothelial Growth Factor B market competition by top manufacturers/players, with Vascular Endothelial Growth Factor B sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Alteogen Inc
    CSL Ltd
    Eli Lilly and Company
    Formycon AG
    Regeneron Pharmaceuticals Inc
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Aflibercept
    Aflibercept Biosimilar
    CSL-346
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Rectal Cancer
    Retinal Vein Occlusion
    Diabetic Nephropathy
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Vascular Endothelial Growth Factor B Sales Market Report 2017
1 Vascular Endothelial Growth Factor B Market Overview
    1.1 Product Overview and Scope of Vascular Endothelial Growth Factor B
    1.2 Classification of Vascular Endothelial Growth Factor B by Product Category
        1.2.1 Global Vascular Endothelial Growth Factor B Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Vascular Endothelial Growth Factor B Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Aflibercept
        1.2.4 Aflibercept Biosimilar
        1.2.5 CSL-346
        1.2.6 Others
    1.3 Global Vascular Endothelial Growth Factor B Market by Application/End Users
        1.3.1 Global Vascular Endothelial Growth Factor B Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Rectal Cancer
        1.3.3 Retinal Vein Occlusion
        1.3.4 Diabetic Nephropathy
        1.3.5 Others
    1.4 Global Vascular Endothelial Growth Factor B Market by Region
        1.4.1 Global Vascular Endothelial Growth Factor B Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Vascular Endothelial Growth Factor B Status and Prospect (2012-2022)
        1.4.3 China Vascular Endothelial Growth Factor B Status and Prospect (2012-2022)
        1.4.4 Europe Vascular Endothelial Growth Factor B Status and Prospect (2012-2022)
        1.4.5 Japan Vascular Endothelial Growth Factor B Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Vascular Endothelial Growth Factor B Status and Prospect (2012-2022)
        1.4.7 India Vascular Endothelial Growth Factor B Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Vascular Endothelial Growth Factor B (2012-2022)
        1.5.1 Global Vascular Endothelial Growth Factor B Sales and Growth Rate (2012-2022)
        1.5.2 Global Vascular Endothelial Growth Factor B Revenue and Growth Rate (2012-2022)

2 Global Vascular Endothelial Growth Factor B Competition by Players/Suppliers, Type and Application
     2.1 Global Vascular Endothelial Growth Factor B Market Competition by Players/Suppliers
        2.1.1 Global Vascular Endothelial Growth Factor B Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Vascular Endothelial Growth Factor B Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Vascular Endothelial Growth Factor B (Volume and Value) by Type
        2.2.1 Global Vascular Endothelial Growth Factor B Sales and Market Share by Type (2012-2017)
        2.2.2 Global Vascular Endothelial Growth Factor B Revenue and Market Share by Type (2012-2017)
    2.3 Global Vascular Endothelial Growth Factor B (Volume and Value) by Region
        2.3.1 Global Vascular Endothelial Growth Factor B Sales and Market Share by Region (2012-2017)
        2.3.2 Global Vascular Endothelial Growth Factor B Revenue and Market Share by Region (2012-2017)
    2.4 Global Vascular Endothelial Growth Factor B (Volume) by Application

3 United States Vascular Endothelial Growth Factor B (Volume, Value and Sales Price)
    3.1 United States Vascular Endothelial Growth Factor B Sales and Value (2012-2017)
        3.1.1 United States Vascular Endothelial Growth Factor B Sales and Growth Rate (2012-2017)
        3.1.2 United States Vascular Endothelial Growth Factor B Revenue and Growth Rate (2012-2017)
        3.1.3 United States Vascular Endothelial Growth Factor B Sales Price Trend (2012-2017)
    3.2 United States Vascular Endothelial Growth Factor B Sales Volume and Market Share by Players
    3.3 United States Vascular Endothelial Growth Factor B Sales Volume and Market Share by Type
    3.4 United States Vascular Endothelial Growth Factor B Sales Volume and Market Share by Application

4 China Vascular Endothelial Growth Factor B (Volume, Value and Sales Price)
    4.1 China Vascular Endothelial Growth Factor B Sales and Value (2012-2017)
        4.1.1 China Vascular Endothelial Growth Factor B Sales and Growth Rate (2012-2017)
        4.1.2 China Vascular Endothelial Growth Factor B Revenue and Growth Rate (2012-2017)
        4.1.3 China Vascular Endothelial Growth Factor B Sales Price Trend (2012-2017)
    4.2 China Vascular Endothelial Growth Factor B Sales Volume and Market Share by Players
    4.3 China Vascular Endothelial Growth Factor B Sales Volume and Market Share by Type
    4.4 China Vascular Endothelial Growth Factor B Sales Volume and Market Share by Application

5 Europe Vascular Endothelial Growth Factor B (Volume, Value and Sales Price)
    5.1 Europe Vascular Endothelial Growth Factor B Sales and Value (2012-2017)
        5.1.1 Europe Vascular Endothelial Growth Factor B Sales and Growth Rate (2012-2017)
        5.1.2 Europe Vascular Endothelial Growth Factor B Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Vascular Endothelial Growth Factor B Sales Price Trend (2012-2017)
    5.2 Europe Vascular Endothelial Growth Factor B Sales Volume and Market Share by Players
    5.3 Europe Vascular Endothelial Growth Factor B Sales Volume and Market Share by Type
    5.4 Europe Vascular Endothelial Growth Factor B Sales Volume and Market Share by Application

6 Japan Vascular Endothelial Growth Factor B (Volume, Value and Sales Price)
    6.1 Japan Vascular Endothelial Growth Factor B Sales and Value (2012-2017)
        6.1.1 Japan Vascular Endothelial Growth Factor B Sales and Growth Rate (2012-2017)
        6.1.2 Japan Vascular Endothelial Growth Factor B Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Vascular Endothelial Growth Factor B Sales Price Trend (2012-2017)
    6.2 Japan Vascular Endothelial Growth Factor B Sales Volume and Market Share by Players
    6.3 Japan Vascular Endothelial Growth Factor B Sales Volume and Market Share by Type
    6.4 Japan Vascular Endothelial Growth Factor B Sales Volume and Market Share by Application

7 Southeast Asia Vascular Endothelial Growth Factor B (Volume, Value and Sales Price)
    7.1 Southeast Asia Vascular Endothelial Growth Factor B Sales and Value (2012-2017)
        7.1.1 Southeast Asia Vascular Endothelial Growth Factor B Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Vascular Endothelial Growth Factor B Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Vascular Endothelial Growth Factor B Sales Price Trend (2012-2017)
    7.2 Southeast Asia Vascular Endothelial Growth Factor B Sales Volume and Market Share by Players
    7.3 Southeast Asia Vascular Endothelial Growth Factor B Sales Volume and Market Share by Type
    7.4 Southeast Asia Vascular Endothelial Growth Factor B Sales Volume and Market Share by Application

8 India Vascular Endothelial Growth Factor B (Volume, Value and Sales Price)
    8.1 India Vascular Endothelial Growth Factor B Sales and Value (2012-2017)
        8.1.1 India Vascular Endothelial Growth Factor B Sales and Growth Rate (2012-2017)
        8.1.2 India Vascular Endothelial Growth Factor B Revenue and Growth Rate (2012-2017)
        8.1.3 India Vascular Endothelial Growth Factor B Sales Price Trend (2012-2017)
    8.2 India Vascular Endothelial Growth Factor B Sales Volume and Market Share by Players
    8.3 India Vascular Endothelial Growth Factor B Sales Volume and Market Share by Type
    8.4 India Vascular Endothelial Growth Factor B Sales Volume and Market Share by Application

9 Global Vascular Endothelial Growth Factor B Players/Suppliers Profiles and Sales Data
    9.1 Alteogen Inc
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Vascular Endothelial Growth Factor B Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 CSL Ltd
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Vascular Endothelial Growth Factor B Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Eli Lilly and Company
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Vascular Endothelial Growth Factor B Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Formycon AG
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Vascular Endothelial Growth Factor B Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Regeneron Pharmaceuticals Inc
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Vascular Endothelial Growth Factor B Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    ...

10 Vascular Endothelial Growth Factor B Maufacturing Cost Analysis
    10.1 Vascular Endothelial Growth Factor B Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Vascular Endothelial Growth Factor B
    10.3 Manufacturing Process Analysis of Vascular Endothelial Growth Factor B

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Vascular Endothelial Growth Factor B Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Vascular Endothelial Growth Factor B Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Vascular Endothelial Growth Factor B Market Forecast (2017-2022)
    14.1 Global Vascular Endothelial Growth Factor B Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Vascular Endothelial Growth Factor B Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Vascular Endothelial Growth Factor B Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Vascular Endothelial Growth Factor B Price and Trend Forecast (2017-2022)
    14.2 Global Vascular Endothelial Growth Factor B Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Vascular Endothelial Growth Factor B Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Vascular Endothelial Growth Factor B Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Vascular Endothelial Growth Factor B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Vascular Endothelial Growth Factor B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Vascular Endothelial Growth Factor B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Vascular Endothelial Growth Factor B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Vascular Endothelial Growth Factor B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Vascular Endothelial Growth Factor B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Vascular Endothelial Growth Factor B Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Vascular Endothelial Growth Factor B Sales Forecast by Type (2017-2022)
       14.3.2 Global Vascular Endothelial Growth Factor B Revenue Forecast by Type (2017-2022)
       14.3.3 Global Vascular Endothelial Growth Factor B Price Forecast by Type (2017-2022)
    14.4 Global Vascular Endothelial Growth Factor B Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer